Ownership history in Pendal Group Ltd · 21 quarters on record
This page tracks every 13F SEC filing in which Pendal Group Ltd reported a position in BIOGEN INC (BIIB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | ADDED | 13,914 | +9,429 | +210.2% | 0.04% | $3.7M | $267.00 |
| 2022 Q2 | REDUCED | 4,485 | -2,668 | -37.3% | 0.01% | $915K | $203.94 |
| 2022 Q1 | ADDED | 7,153 | +4,111 | +135.1% | 0.01% | $1.5M | $210.60 |
| 2021 Q4 | ADDED | 3,042 | +1,608 | +112.1% | 0.01% | $730K | $239.92 |
| 2021 Q3 | REDUCED | 1,434 | -104 | -6.8% | 0.00% | $406K | $282.99 |
| 2021 Q2 | REDUCED | 1,538 | -11,359 | -88.1% | 0.00% | $533K | $346.27 |
| 2020 Q4 | REDUCED | 12,897 | -14,116 | -52.3% | 0.03% | $3.2M | $244.86 |
| 2020 Q3 | REDUCED | 27,013 | -8,025 | -22.9% | 0.09% | $7.7M | $283.68 |
| 2020 Q2 | ADDED | 35,038 | +12,780 | +57.4% | 0.13% | $9.4M | $267.55 |
| 2020 Q1 | REDUCED | 22,258 | -25,873 | -53.8% | 0.12% | $7.0M | $316.38 |
As of 2025 Q4 — sorted by position size